MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%
Sector Heatmap
Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%
SANA — Sana Biotechnology, Inc. Common Stock
NasdaqSana Biotechnology, Inc. Common Stock
$2.79
+0.07(+2.57%)
- O
- 2.72
- H
- 2.81
- L
- 2.66
- V
- 4.5M
⏱️ End-of-day dataAs of Oct 8, 2026
Chart
About SANA
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateFeb 4, 2021
Employees142
Stock ExchangeNasdaq
Ticker SymbolSANA
Websitehttps://www.sana.com
Key Financial Statistics
| Market Cap | $865.15M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.61 - $6.55 |
| 52-Week Avg Volume | 3.72M |
| VWAP | $2.76 |
| Transactions | 16,826 |
| Total Recorded Bars | 1,426 days |